Korea United Pharm Inc
KRX:033270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puma SE
XETRA:PUM
|
DE |
|
H
|
Hefei Metalforming Intelligent Manufacturing Co Ltd
SSE:603011
|
CN |
|
Sihui Fuji Electronics Technology Co Ltd
SZSE:300852
|
CN |
|
Muthoot Finance Ltd
NSE:MUTHOOTFIN
|
IN |
Korea United Pharm Inc
Other Current Liabilities
Korea United Pharm Inc
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Korea United Pharm Inc
KRX:033270
|
Other Current Liabilities
₩13.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
|
Yuhan Corp
KRX:000100
|
Other Current Liabilities
₩253.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Other Current Liabilities
₩182.8B
|
CAGR 3-Years
32%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Other Current Liabilities
₩149.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-10%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Other Current Liabilities
₩30.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
22%
|
CAGR 10-Years
14%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Other Current Liabilities
₩5.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Korea United Pharm Inc
Glance View
KOREA UNITED PHARM, Inc. engages in the manufacture and distribution of pharmaceuticals and healthcare products. The company is headquartered in Sejong, Sejong and currently employs 885 full-time employees. The company went IPO on 2007-10-23. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company’s products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. The company also provides active pharmaceutical ingredients (APIs) and various health food products. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Korea United Pharm Inc's Other Current Liabilities?
Other Current Liabilities
13.7B
KRW
Based on the financial report for Sep 30, 2025, Korea United Pharm Inc's Other Current Liabilities amounts to 13.7B KRW.
What is Korea United Pharm Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
8%
Over the last year, the Other Current Liabilities growth was -15%. The average annual Other Current Liabilities growth rates for Korea United Pharm Inc have been -8% over the past three years , 1% over the past five years , and 8% over the past ten years .
